About Octapharma
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines.
Octapharma employs more than 11,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology, and Critical Care.
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centres across Europe and the US.
Check our community guidelines: https://bit.ly/3M8ioml
|
|
|
1,001-5,000 employees
View all Octapharma employees
|
|
Pharmaceutical Manufacturing
|
|
Seidenstrasse 2, Lachen, Switzerland 8853, CH
|
|
1983
|
|
Critical Care, Immunotherapy, Haematology, Plasma Fractionation
|
Octapharma Alternatives
Frequently Asked Questions about Octapharma
Joseph Daktar is the CEO of Octapharma. To contact Joseph Daktar email at [email protected].
The decision makers in Octapharma are Abel Vizeu Fernandes, Dmitri Titov, Gaetan Fournier, etc. Click to Find Octapharma decision makers emails.
Octapharma specializes in the development and production of human proteins derived from human plasma and human cell lines. Their product portfolio includes therapies for critical care, immunotherapy, and hematology, focusing on conditions such as hemophilia, immune deficiencies, and other serious medical conditions.
Octapharma adheres to stringent quality control measures throughout the manufacturing process. The company follows Good Manufacturing Practices (GMP) and conducts extensive testing for safety, efficacy, and purity. Additionally, Octapharma's products undergo rigorous clinical trials and are continuously monitored post-market to ensure ongoing safety and effectiveness.
Octapharma supports various industries, primarily focusing on healthcare and pharmaceuticals. Their products are utilized in hospitals, clinics, and healthcare facilities worldwide, particularly in the fields of critical care, immunotherapy, and hematology. They also engage in research and development to advance therapies for rare and complex diseases.
Yes, healthcare professionals can access Octapharma's products through authorized distributors and healthcare channels. The company provides comprehensive information and support to medical professionals regarding the appropriate use of their therapies, ensuring that patients receive the best possible treatment.
Plasma fractionation is a process that separates the various components of human plasma to extract valuable proteins for therapeutic use. Octapharma employs advanced plasma fractionation techniques to produce high-quality human proteins, ensuring that their therapies are safe and effective for patients with specific medical needs.
Yes, Octapharma is committed to research and development, investing significantly in innovative therapies to address unmet medical needs. The company collaborates with academic institutions and healthcare professionals to advance the science of human proteins and develop new treatment options for patients with rare and complex diseases.
Octapharma Staff Directory
Search Octapharma Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
